semaglutide and cardiovascular Outcomes in Patients with Type 2 Diabetes Semaglutide cardiovascular outcomes align more

Maintenance of lost weight and long-term management of obesity

Effect of Pasteurized Akkermansia Muciniphilia on Maintenance of Body Weight After a Low Calorie Diet

Drug screening and sports doping contexts In competitive sports, semaglutide is classified as a peptide hormone that could be monitored in anti-doping programs

The ongoing CONFIDENCE trial (NCT05254002) is an international randomised controlled double-blind trial that will directly assess the effects of finerenone plus empagliflozin on albuminuria and characterise the efficacy and safety of this drug combination in the setting of type 2 diabetes

Never adjust your medication dosage without consulting your healthcare provider, as this could affect diabetes management and glycaemic control

GLP-1 tablets may lead to more variable absorption patterns, particularly in the early weeks of therapy